InvestorsObserver
×
News Home

Is Ardelyx Inc (ARDX) a Smart Choice in Biotechnology Friday?

Friday, November 24, 2023 11:29 AM | InvestorsObserver Analysts

Mentioned in this article

Is Ardelyx Inc (ARDX) a Smart Choice in Biotechnology Friday?

A rating of 98 puts Ardelyx Inc (ARDX) near the top of the Biotechnology industry according to InvestorsObserver. Ardelyx Inc's score of 98 means it scores higher than 98% of stocks in the industry. Ardelyx Inc also received an overall rating of 85, putting it above 85% of all stocks. Biotechnology is ranked 49 out of the 148 industries.

Overall Score - 85
ARDX has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on ARDX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 85 would rank higher than 85 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Ardelyx Inc Stock Today?

Ardelyx Inc (ARDX) stock is higher by 0.93% while the S&P 500 has fallen -0.03% as of 11:26 AM on Friday, Nov 24. ARDX is higher by $0.04 from the previous closing price of $4.31 on volume of 1,155,336 shares. Over the past year the S&P 500 has gained 13.14% while ARDX is higher by 136.41%. ARDX lost -$0.12 per share the over the last 12 months. Click Here to get the full Stock Report for Ardelyx Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App